<DOC>
	<DOCNO>NCT01566461</DOCNO>
	<brief_summary>The purpose study demonstrate safety efficacy IN.PACT Admiral drug-coated balloon ( DCB ) comparison standard balloon treatment peripheral arterial disease ( PAD ) superficial femoral artery proximal popliteal artery .</brief_summary>
	<brief_title>IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty Treatment Superficial Femoral Artery ( SFA ) Proximal Popliteal Artery ( PPA )</brief_title>
	<detailed_description>The IN.PACT SFA Trial enrol 2 phase : IN.PACT SFA I IN.PACT SFA II . The 150-patient IN.PACT SFA I phase intended support second phase IN.PACT SFA II IDE trial congruent design protocol . Aggregate data two phase intend provide statistical power 12-month primary safety effectiveness endpoint .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Age : &gt; equal 18 year &lt; equal 85 year Documented ischemia Rutherford classification 2 , 3 , 4 Target lesion SFA and/or PPA Angiographic evidence target lesion consist single de novo nonstented restenotic lesion combination lesion meet follow criterion : 1 . 70 99 % occlusion visual estimate lesion length &gt; equal 4 cm &lt; equal 18 cm 2 . 100 % occlusion visual estimate lesion length &lt; equal 10 cm 3 . Combination lesion must total lesion length &gt; equal 4 cm &lt; equal 18 cm occlude segment &lt; equal 10 cm ( visual estimate ) Target vessel diameter &gt; equal 4 mm &lt; equal 7 mm Angiographic evidence adequate distal runoff ankle Able walk without assistive device Stroke heart attack within 3 month prior enrollment Enrolled another investigational drug , device biologic study Any surgical procedure intervention perform within 30 day prior post index procedure SFA PPA disease opposite leg require treatment index procedure Failure successfully cross target lesion Angiographic evidence severe calcification Target lesion require treatment alternative therapy stenting , laser , atherectomy , cryoplasty , brachytherapy , reentry device ) Known allergy sensitivity heparin , aspirin , anticoagulant/antiplatelet therapy , paclitaxel contrast medium adequately pretreated prior index procedure Chronic kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Drug-Coated Angioplasty Balloon</keyword>
	<keyword>Drug Coated Angioplasty Balloon</keyword>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Experimental</keyword>
	<keyword>Percutaneous Transluminal Angioplasty ( PTA )</keyword>
</DOC>